glp-1 or semaglutide Another Weight-Loss Trial Win for Weekly Drug Tirzepatide vs Semaglutide: What You
Description
However, treatment with semaglutide was associated with occurrence of NAION, despite the fact that no definitive conclusions regarding this association could be drawn. Clinical Implications Semaglutide does not appear to increase or reduce risk for DR or general ocular adverse events
June 12th, 2025: EMA Links Semaglutide to Rare Vision Disorder The European Medicines Agency (EMA) has formally acknowledged a potential link between semaglutide, the key ingredient in Ozempic, Wegovy, and Rybelsus, and a rare but serious eye condition known as non-arteritic anterior ischemic optic neuropathy (NAION)
What diabetes medications are safe to take whilst breastfeeding
Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation
pre-existing biomarkers can contextualize risk
